menu
    • menu

    Company profile for Yumanity Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Yumanity Therapeutics was founded in December 2014 to serve the millions of people affected by neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Since then, we have assembled a highly skilled team of scientists and innovators deeply committed to identifying and developing new, disease-modifying therapies that address th...
    Yumanity Therapeutics was founded in December 2014 to serve the millions of people affected by neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease. Since then, we have assembled a highly skilled team of scientists and innovators deeply committed to identifying and developing new, disease-modifying therapies that address these conditions. Each of our lives have been affected by the ravages of neurodegenerative diseases and it is these personal experiences that inspire our commitment to finding therapies for such devastating diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Yumanity TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    790 Memorial Drive, Suite 2C Cambridge, MA 02139
    Telephone
    Telephone
    617-409-5300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.yumanity.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/yumanity-therapeutics
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/yumanitytx?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Yumanity Declares Special Dividend In Connection with Proposed Asset Sale
    Yumanity Declares Special Dividend In Connection with Proposed Asset Sale

    05 Dec 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2022/12/05/2567286/0/en/Yumanity-Therapeutics-Declares-Special-Dividend-In-Connection-with-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta.html

    GLOBENEWSWIRE
    05 Dec 2022
    Share Share
    Yumanity Therapeutics Reports 3Q 2022 Financial Results
    Yumanity Therapeutics Reports 3Q 2022 Financial Results

    14 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/14/2555009/0/en/Yumanity-Therapeutics-Reports-Third-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    14 Nov 2022
    Share Share
    Yumanity Therapeutics Announces Effectiveness of Registration Statement
    Yumanity Therapeutics Announces Effectiveness of Registration Statement

    10 Nov 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/11/10/2553838/0/en/Yumanity-Therapeutics-Announces-Effectiveness-of-Registration-Statement-on-Form-S-4-In-Connection-With-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta-Inc.html

    GLOBENEWSWIRE
    10 Nov 2022
    Share Share
    Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4
    Yumanity Therapeutics Announces Filing of Registration Statement on Form S-4

    29 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/29/2505759/0/en/Yumanity-Therapeutics-Announces-Filing-of-Registration-Statement-on-Form-S-4-In-Connection-With-Proposed-Asset-Sale-to-Janssen-and-Merger-with-Kineta.html

    GLOBENEWSWIRE
    29 Aug 2022
    Share Share
    Yumanity Therapeutics Reports Second Quarter 2022 Financial Results
    Yumanity Therapeutics Reports Second Quarter 2022 Financial Results

    04 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/04/2492847/0/en/Yumanity-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    04 Aug 2022
    Share Share
    Yumanity Announces Definitive Agreements for Two Strategic Transactions
    Yumanity Announces Definitive Agreements for Two Strategic Transactions

    06 Jun 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/06/06/2456507/0/en/Yumanity-Therapeutics-Announces-Definitive-Agreements-for-Two-Strategic-Transactions.html

    GLOBENEWSWIRE
    06 Jun 2022
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search